Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA
The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8 + T cells 1 , 2 , 3 . HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by...
Saved in:
Published in | Nature (London) Vol. 432; no. 7018; pp. 769 - 775 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
09.12.2004
Nature Publishing Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8
+
T cells
1
,
2
,
3
. HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by CD8
+
T cells. However, the relative contributions of HLA-A and -B alleles have not been evaluated. We performed a comprehensive analysis of the class I restricted CD8
+
T-cell responses against human immunodeficiency virus (HIV-1), immune control of which is dependent upon virus-specific CD8
+
T-cell activity
4
,
5
. In 375 HIV-1-infected study subjects from southern Africa, a significantly greater number of CD8
+
T-cell responses are HLA-B-restricted, compared to HLA-A (2.5-fold;
P
= 0.0033). Here we show that variation in viral set-point, in absolute CD4 count and, by inference, in rate of disease progression in the cohort, is strongly associated with particular HLA-B but not HLA-A allele expression (
P
< 0.0001 and
P
= 0.91, respectively). Moreover, substantially greater selection pressure is imposed on HIV-1 by HLA-B alleles than by HLA-A (4.4-fold,
P
= 0.0003). These data indicate that the principal focus of HIV-specific activity is at the HLA-B locus. Furthermore, HLA-B gene frequencies in the population are those likely to be most influenced by HIV disease, consistent with the observation that B alleles evolve more rapidly than A alleles
6
,
7
,
8
. The dominant involvement of HLA-B in influencing HIV disease outcome is of specific relevance to the direction of HIV research and to vaccine design. |
---|---|
AbstractList | The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8 super(+) T cells. HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by CD8 super(+) T cells. However, the relative contributions of HLA-A and-B alleles have not been evaluated. We performed a comprehensive analysis of the class I restricted CD8 super(+) T-cell responses against human immunodeficiency virus (HIV-1), immune control of which is dependent upon virus-specific CD8 super(+) T-cell activity. In 375 HIV-1-infected study subjects from southern Africa, a significantly greater number of CD8 super(+) T-cell responses are HLA-B-restricted, compared to HLA-A (2.5-fold; P = 0.0033). Here we show that variation in viral set-point, in absolute CD4 count and, by inference, in rate of disease progression in the cohort, is strongly associated with particular HLA-B but not HLA-A allele expression (P < 0.0001 and P = 0.91, respectively). Moreover, substantially greater selection pressure is imposed on HIV-1 by HLA-B alleles than by HLA-A (4.4-fold, P = 0.0003). These data indicate that the principal focus of HIV-specific activity is at the HLA-B locus. Furthermore, HLA-B gene frequencies in the population are those likely to be most influenced by HIV disease, consistent with the observation that B alleles evolve more rapidly than A alleles. The dominant involvement of HLA-B in influencing HIV disease outcome is of specific relevance to the direction of HIV research and to vaccine design. The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8 + T cells 1 , 2 , 3 . HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by CD8 + T cells. However, the relative contributions of HLA-A and -B alleles have not been evaluated. We performed a comprehensive analysis of the class I restricted CD8 + T-cell responses against human immunodeficiency virus (HIV-1), immune control of which is dependent upon virus-specific CD8 + T-cell activity 4 , 5 . In 375 HIV-1-infected study subjects from southern Africa, a significantly greater number of CD8 + T-cell responses are HLA-B-restricted, compared to HLA-A (2.5-fold; P = 0.0033). Here we show that variation in viral set-point, in absolute CD4 count and, by inference, in rate of disease progression in the cohort, is strongly associated with particular HLA-B but not HLA-A allele expression ( P < 0.0001 and P = 0.91, respectively). Moreover, substantially greater selection pressure is imposed on HIV-1 by HLA-B alleles than by HLA-A (4.4-fold, P = 0.0003). These data indicate that the principal focus of HIV-specific activity is at the HLA-B locus. Furthermore, HLA-B gene frequencies in the population are those likely to be most influenced by HIV disease, consistent with the observation that B alleles evolve more rapidly than A alleles 6 , 7 , 8 . The dominant involvement of HLA-B in influencing HIV disease outcome is of specific relevance to the direction of HIV research and to vaccine design. The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8+ T cells. HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by CD8+ T cells. However, the relative contributions of HLA-A and -B alleles have not been evaluated. We performed a comprehensive analysis of the class I restricted CD8+ T-cell responses against human immunodeficiency virus (HIV-1), immune control of which is dependent upon virus-specific CD8+ T-cell activity. In 375 HIV-1-infected study subjects from southern Africa, a significantly greater number of CD8+ T-cell responses are HLA-B-restricted, compared to HLA-A (2.5-fold; P = 0.0033). Here we show that variation in viral set-point, in absolute CD4 count and, by inference, in rate of disease progression in the cohort, is strongly associated with particular HLA-B but not HLA-A allele expression (P < 0.0001 and P = 0.91, respectively). Moreover, substantially greater selection pressure is imposed on HIV-1 by HLA-B alleles than by HLA-A (4.4-fold, P = 0.0003). These data indicate that the principal focus of HIV-specific activity is at the HLA-B locus. Furthermore, HLA-B gene frequencies in the population are those likely to be most influenced by HIV disease, consistent with the observation that B alleles evolve more rapidly than A alleles. The dominant involvement of HLA-B in influencing HIV disease outcome is of specific relevance to the direction of HIV research and to vaccine design.The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8+ T cells. HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by CD8+ T cells. However, the relative contributions of HLA-A and -B alleles have not been evaluated. We performed a comprehensive analysis of the class I restricted CD8+ T-cell responses against human immunodeficiency virus (HIV-1), immune control of which is dependent upon virus-specific CD8+ T-cell activity. In 375 HIV-1-infected study subjects from southern Africa, a significantly greater number of CD8+ T-cell responses are HLA-B-restricted, compared to HLA-A (2.5-fold; P = 0.0033). Here we show that variation in viral set-point, in absolute CD4 count and, by inference, in rate of disease progression in the cohort, is strongly associated with particular HLA-B but not HLA-A allele expression (P < 0.0001 and P = 0.91, respectively). Moreover, substantially greater selection pressure is imposed on HIV-1 by HLA-B alleles than by HLA-A (4.4-fold, P = 0.0003). These data indicate that the principal focus of HIV-specific activity is at the HLA-B locus. Furthermore, HLA-B gene frequencies in the population are those likely to be most influenced by HIV disease, consistent with the observation that B alleles evolve more rapidly than A alleles. The dominant involvement of HLA-B in influencing HIV disease outcome is of specific relevance to the direction of HIV research and to vaccine design. The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8+ T cells. HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by CD8+ T cells. However, the relative contributions of HLA-A and -B alleles have not been evaluated. We performed a comprehensive analysis of the class I restricted CD8+ T-cell responses against human immunodeficiency virus (HIV-1), immune control of which is dependent upon virus-specific CD8+ T-cell activity. In 375 HIV-1-infected study subjects from southern Africa, a significantly greater number of CD8+ T-cell responses are HLA-B-restricted, compared to HLA-A (2.5-fold; P = 0.0033). Here we show that variation in viral set-point, in absolute CD4 count and, by inference, in rate of disease progression in the cohort, is strongly associated with particular HLA-B but not HLA-A allele expression (P < 0.0001 and P = 0.91, respectively). Moreover, substantially greater selection pressure is imposed on HIV-1 by HLA-B alleles than by HLA-A (4.4-fold, P = 0.0003). These data indicate that the principal focus of HIV-specific activity is at the HLA-B locus. Furthermore, HLA-B gene frequencies in the population are those likely to be most influenced by HIV disease, consistent with the observation that B alleles evolve more rapidly than A alleles. The dominant involvement of HLA-B in influencing HIV disease outcome is of specific relevance to the direction of HIV research and to vaccine design. The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence mediated by CD8+ T cells. HLA class I molecules present pathogen-derived peptides on the surface of infected cells for recognition by CD8+ T cells. However, the relative contributions of HLA-A and -B alleles have not been evaluated. We performed a comprehensive analysis of the class I restricted CD8+ T-cell responses against human immunodeficiency virus (HIV-1), immune control of which is dependent upon virus-specific CD8+ T-cell activity. In 375 HIV-1-infected study subjects from southern Africa, a significantly greater number of CD8+ T-cell responses are HLA-B-restricted, compared to HLA-A (2.5-fold; P = 0.0033). Here we show that variation in viral set-point, in absolute CD4 count and, by inference, in rate of disease progression in the cohort, is strongly associated with particular HLA-B but not HLA-A allele expression (P < 0.0001 and P = 0.91, respectively). Moreover, substantially greater selection pressure is imposed on HIV-1 by HLA-B alleles than by HLA-A (4.4-fold, P = 0.0003). These data indicate that the principal focus of HIV-specific activity is at the HLA-B locus. Furthermore, HLA-B gene frequencies in the population are those likely to be most influenced by HIV disease, consistent with the observation that B alleles evolve more rapidly than A alleles. The dominant involvement of HLA-B in influencing HIV disease outcome is of specific relevance to the direction of HIV research and to vaccine design. [PUBLICATION ABSTRACT] |
Audience | Academic |
Author | Goulder, Philip J. R. Honeyborne, Isobella Chetty, Senica Allen, Todd James, Ian Coovadia, Hoosen M. Brander, Christian Thobakgale, Christina Korber, Bette Walker, Bruce D. Klenerman, Paul Day, Cheryl Moore, Corey Ramduth, Danni Zimbwa, Peter Rathnavalu, Prinisha Kiepiela, Photini Addo, Marylyn M. Hilton, Louise Mullins, James Mallal, Simon Szinger, James Leslie, Alasdair J. Moore, Sarah Altfeld, Marcus Barber, Linda D. Pfafferott, Katja J. Bunce, Michael |
Author_xml | – sequence: 1 givenname: Photini surname: Kiepiela fullname: Kiepiela, Photini organization: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZuluNatal – sequence: 2 givenname: Alasdair J. surname: Leslie fullname: Leslie, Alasdair J. organization: Department of Paediatrics, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research – sequence: 3 givenname: Isobella surname: Honeyborne fullname: Honeyborne, Isobella organization: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZuluNatal, Department of Paediatrics, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research – sequence: 4 givenname: Danni surname: Ramduth fullname: Ramduth, Danni organization: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZuluNatal – sequence: 5 givenname: Christina surname: Thobakgale fullname: Thobakgale, Christina organization: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZuluNatal – sequence: 6 givenname: Senica surname: Chetty fullname: Chetty, Senica organization: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZuluNatal – sequence: 7 givenname: Prinisha surname: Rathnavalu fullname: Rathnavalu, Prinisha organization: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZuluNatal – sequence: 8 givenname: Corey surname: Moore fullname: Moore, Corey organization: Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Level 2 North Block, Royal Perth Hospital – sequence: 9 givenname: Katja J. surname: Pfafferott fullname: Pfafferott, Katja J. organization: Department of Paediatrics, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research – sequence: 10 givenname: Louise surname: Hilton fullname: Hilton, Louise organization: Department of Paediatrics, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research – sequence: 11 givenname: Peter surname: Zimbwa fullname: Zimbwa, Peter organization: Department of Paediatrics, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research – sequence: 12 givenname: Sarah surname: Moore fullname: Moore, Sarah organization: Department of Microbiology, University of Washington – sequence: 13 givenname: Todd surname: Allen fullname: Allen, Todd organization: Partners AIDS Research Center, Massachusetts General Hospital – sequence: 14 givenname: Christian surname: Brander fullname: Brander, Christian organization: Partners AIDS Research Center, Massachusetts General Hospital – sequence: 15 givenname: Marylyn M. surname: Addo fullname: Addo, Marylyn M. organization: Partners AIDS Research Center, Massachusetts General Hospital – sequence: 16 givenname: Marcus surname: Altfeld fullname: Altfeld, Marcus organization: Partners AIDS Research Center, Massachusetts General Hospital – sequence: 17 givenname: Ian surname: James fullname: James, Ian organization: Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Level 2 North Block, Royal Perth Hospital – sequence: 18 givenname: Simon surname: Mallal fullname: Mallal, Simon organization: Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Level 2 North Block, Royal Perth Hospital – sequence: 19 givenname: Michael surname: Bunce fullname: Bunce, Michael organization: Dynal Biotech Ltd – sequence: 20 givenname: Linda D. surname: Barber fullname: Barber, Linda D. organization: Anthony Nolan Research Institute, Royal Free Hospital – sequence: 21 givenname: James surname: Szinger fullname: Szinger, James organization: Santa Fe Institute, Los Alamos National Laboratory – sequence: 22 givenname: Cheryl surname: Day fullname: Day, Cheryl organization: Department of Paediatrics, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research – sequence: 23 givenname: Paul surname: Klenerman fullname: Klenerman, Paul organization: Department of Paediatrics, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research – sequence: 24 givenname: James surname: Mullins fullname: Mullins, James organization: Department of Microbiology, University of Washington – sequence: 25 givenname: Bette surname: Korber fullname: Korber, Bette organization: Santa Fe Institute, Los Alamos National Laboratory – sequence: 26 givenname: Hoosen M. surname: Coovadia fullname: Coovadia, Hoosen M. organization: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZuluNatal – sequence: 27 givenname: Bruce D. surname: Walker fullname: Walker, Bruce D. organization: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZuluNatal, Partners AIDS Research Center, Massachusetts General Hospital, Howard Hughes Medical Institute – sequence: 28 givenname: Philip J. R. surname: Goulder fullname: Goulder, Philip J. R. email: philip.goulder@ndm.ox.ac.uk organization: HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZuluNatal, Department of Paediatrics, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, Partners AIDS Research Center, Massachusetts General Hospital |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16328802$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15592417$$D View this record in MEDLINE/PubMed |
BookMark | eNqF0l1v0zAUBuAIDbFucMU9ipAGQpDhr9jOZSkfm1SBNAZcRq5zXDyldmc7CP49Li3qOnXgXFiynvNaOT5HxYHzDoriMUanGFH52qk0BEAUY3qvGGEmeMW4FAfFCCEiKyQpPyyOYrxCCNVYsAfFIa7rhjAsRsXFW7-wTrlUWmf6AZyG0pvybDqu3uSjcgGdVcm6eZm-Q7n0CVyyqi-1r-CH74dkvftTcP61VK5bFT4s7hvVR3i02Y-LL-_fXU7OqumnD-eT8bTSXLJUNZyBZKrptGJAZGNmXadI3aGGzggHg5ikTNMaCc6EVsgoY3BGRFLTcETpcfF8nbsM_nqAmNqFjRr6XjnwQ2wFo5iLhq3ks39KLrBkNeX_hVjwpiGYZfj0FrzyQ3D5d1uCWJ1XgzOq1miuemhzf30KSs_BQVB9fkNj8_EYS04kp0RsQ3e8Xtrr9iY63YPy18HC6r2pL3YKsknwM83VEGN7_vli1768244vv00-7uonmyYMszwn7TLYhQq_2r_TlcHJBqioVW-CctrGrcspUiKyvVYHH2MAsyWoXc14e2PGs8a3tLZJrQYxd8L2d9S8WtfEnOzmELbvtY__BrUXB_M |
CODEN | NATUAS |
CitedBy_id | crossref_primary_10_1093_infdis_jiw093 crossref_primary_10_1586_erv_10_106 crossref_primary_10_1128_JVI_01547_06 crossref_primary_10_1128_JVI_00932_09 crossref_primary_10_1258_jrsm_2009_090183 crossref_primary_10_1371_journal_pone_0030302 crossref_primary_10_1016_j_medj_2024_06_008 crossref_primary_10_1016_j_vaccine_2007_08_020 crossref_primary_10_1128_JVI_01535_21 crossref_primary_10_1089_aid_2012_0160 crossref_primary_10_1371_journal_pone_0040100 crossref_primary_10_1089_aid_2007_0024 crossref_primary_10_1128_JVI_01879_10 crossref_primary_10_1002_eji_200940079 crossref_primary_10_1128_JVI_01020_12 crossref_primary_10_1097_QAD_0000000000000284 crossref_primary_10_1128_JVI_01960_19 crossref_primary_10_1038_s41467_018_07209_7 crossref_primary_10_1097_QAD_0b013e328045c4bd crossref_primary_10_1186_1743_422X_5_141 crossref_primary_10_1136_amiajnl_2012_000867 crossref_primary_10_1128_JVI_02082_16 crossref_primary_10_1038_emi_2012_26 crossref_primary_10_1111_tan_15298 crossref_primary_10_1073_pnas_0500649102 crossref_primary_10_1097_QAI_0b013e3182036f14 crossref_primary_10_1128_JVI_01754_06 crossref_primary_10_1186_1742_4690_10_72 crossref_primary_10_1097_QAD_0000000000001382 crossref_primary_10_1097_QAD_0b013e3282f470e4 crossref_primary_10_1016_j_vaccine_2012_05_049 crossref_primary_10_1128_JVI_02483_09 crossref_primary_10_4049_jimmunol_1302667 crossref_primary_10_1038_icb_2011_34 crossref_primary_10_1089_aid_2016_0168 crossref_primary_10_1002_hep_21889 crossref_primary_10_1007_s11904_006_0003_4 crossref_primary_10_1016_j_virol_2010_06_002 crossref_primary_10_1182_blood_2006_06_030668 crossref_primary_10_1089_aid_2007_0124 crossref_primary_10_1371_journal_pone_0041696 crossref_primary_10_1371_journal_pcbi_1002381 crossref_primary_10_1128_CVI_00015_13 crossref_primary_10_1016_j_jim_2008_11_003 crossref_primary_10_1002_eji_200940295 crossref_primary_10_1038_ng_486 crossref_primary_10_1371_journal_pone_0054300 crossref_primary_10_2217_17469600_1_4_399 crossref_primary_10_1007_s00251_019_01148_3 crossref_primary_10_1128_JVI_02689_06 crossref_primary_10_1128_jvi_01248_22 crossref_primary_10_1038_s41586_023_06370_4 crossref_primary_10_1128_JVI_01409_17 crossref_primary_10_1038_s41467_019_10724_w crossref_primary_10_1371_journal_pbio_1001208 crossref_primary_10_1128_JVI_01480_18 crossref_primary_10_1038_s41576_021_00378_0 crossref_primary_10_1371_journal_pone_0010900 crossref_primary_10_1097_QAD_0b013e3280123840 crossref_primary_10_1089_aid_2012_0171 crossref_primary_10_1177_135965350801300218 crossref_primary_10_1186_1471_2334_9_201 crossref_primary_10_1186_s12977_021_00554_4 crossref_primary_10_1016_j_humimm_2009_08_012 crossref_primary_10_1097_COH_0000000000000541 crossref_primary_10_4049_jimmunol_175_1_367 crossref_primary_10_1038_ng2035 crossref_primary_10_1126_science_aao4572 crossref_primary_10_1007_s11908_007_0012_5 crossref_primary_10_1128_JVI_02084_07 crossref_primary_10_1007_s00439_014_1465_x crossref_primary_10_2217_fvl_11_134 crossref_primary_10_1128_JVI_00624_07 crossref_primary_10_1128_JVI_02607_07 crossref_primary_10_1002_eji_200737365 crossref_primary_10_1097_COH_0000000000000751 crossref_primary_10_1093_infdis_jiz294 crossref_primary_10_4049_jimmunol_1103472 crossref_primary_10_3389_fimmu_2021_669241 crossref_primary_10_1038_nature07746 crossref_primary_10_1038_s41467_019_08311_0 crossref_primary_10_1089_aid_2021_0055 crossref_primary_10_1177_135965350801300508 crossref_primary_10_1128_JVI_80_4_1637_1644_2006 crossref_primary_10_4049_jimmunol_1401017 crossref_primary_10_1126_science_1123016 crossref_primary_10_1038_nri3277 crossref_primary_10_1128_JVI_00804_11 crossref_primary_10_1093_nar_gkv1198 crossref_primary_10_1128_JVI_02276_10 crossref_primary_10_1126_scitranslmed_3003984 crossref_primary_10_4049_jimmunol_1001561 crossref_primary_10_1128_JVI_03464_14 crossref_primary_10_4049_jimmunol_0903227 crossref_primary_10_1038_nm_4100 crossref_primary_10_1371_journal_ppat_1007110 crossref_primary_10_1128_jvi_00954_23 crossref_primary_10_1097_QAD_0b013e3280b07b5b crossref_primary_10_1089_aid_2015_0313 crossref_primary_10_1016_j_bjid_2018_12_002 crossref_primary_10_1128_JVI_03303_13 crossref_primary_10_1128_JVI_00575_06 crossref_primary_10_1007_s00251_017_1010_x crossref_primary_10_1128_JVI_02634_13 crossref_primary_10_1007_s00281_014_0447_3 crossref_primary_10_1016_j_virol_2009_10_002 crossref_primary_10_1093_infdis_jiq122 crossref_primary_10_1128_JVI_01144_10 crossref_primary_10_1093_infdis_jiq125 crossref_primary_10_2174_1570162X17666191017105910 crossref_primary_10_4049_jimmunol_1302101 crossref_primary_10_1097_QAD_0000000000002044 crossref_primary_10_1128_JVI_80_6_3122_3125_2006 crossref_primary_10_1128_JVI_02073_08 crossref_primary_10_1097_QAI_0000000000001458 crossref_primary_10_1111_j_1468_1293_2012_01019_x crossref_primary_10_1128_JVI_00465_07 crossref_primary_10_1371_journal_pone_0058927 crossref_primary_10_2217_hiv_09_57 crossref_primary_10_1016_j_meegid_2016_03_037 crossref_primary_10_4049_jimmunol_0803928 crossref_primary_10_1111_j_1399_0039_2011_01768_x crossref_primary_10_1534_genetics_106_057034 crossref_primary_10_1128_JVI_00921_09 crossref_primary_10_1073_pnas_2008615117 crossref_primary_10_1016_j_heliyon_2024_e33143 crossref_primary_10_1073_pnas_1812548116 crossref_primary_10_1155_2011_549023 crossref_primary_10_3892_mmr_2015_3659 crossref_primary_10_1038_srep10879 crossref_primary_10_3389_fimmu_2018_02361 crossref_primary_10_1089_aid_2006_0131 crossref_primary_10_1128_JVI_79_16_10218_10225_2005 crossref_primary_10_4049_jimmunol_1003711 crossref_primary_10_1016_j_meegid_2009_03_007 crossref_primary_10_3389_fimmu_2015_00546 crossref_primary_10_3390_v14020198 crossref_primary_10_1128_JVI_00539_12 crossref_primary_10_3389_fimmu_2015_00665 crossref_primary_10_1097_QAD_0b013e32833a2b5b crossref_primary_10_1097_01_COH_0000221599_87529_a4 crossref_primary_10_1128_JVI_06150_11 crossref_primary_10_1007_s00251_023_01293_w crossref_primary_10_1371_journal_pmed_1001900 crossref_primary_10_3390_math8010117 crossref_primary_10_1016_j_humimm_2016_06_013 crossref_primary_10_1146_annurev_med_062909_130018 crossref_primary_10_1086_524143 crossref_primary_10_1016_j_molimm_2014_05_016 crossref_primary_10_1097_QAI_0000000000000901 crossref_primary_10_1111_tan_14256 crossref_primary_10_3389_fimmu_2017_01496 crossref_primary_10_1182_blood_2005_01_0243 crossref_primary_10_1371_journal_pone_0006965 crossref_primary_10_2217_hiv_10_26 crossref_primary_10_1002_eji_201040339 crossref_primary_10_1038_nature08997 crossref_primary_10_1371_journal_pone_0024254 crossref_primary_10_4049_jimmunol_1403074 crossref_primary_10_1111_j_1365_2567_2009_03201_x crossref_primary_10_1371_journal_pone_0130420 crossref_primary_10_1097_QAI_0000000000002077 crossref_primary_10_1128_JVI_00819_16 crossref_primary_10_1038_s41598_018_23849_7 crossref_primary_10_1128_JVI_02131_12 crossref_primary_10_1371_journal_pone_0176418 crossref_primary_10_1016_j_ijid_2022_12_016 crossref_primary_10_1016_j_coi_2006_05_012 crossref_primary_10_1128_JVI_00912_06 crossref_primary_10_1371_journal_ppat_1010965 crossref_primary_10_1016_j_coi_2006_05_015 crossref_primary_10_1146_annurev_ecolsys_38_091206_095722 crossref_primary_10_1084_jem_20052116 crossref_primary_10_1002_rmv_577 crossref_primary_10_1007_s00251_012_0645_x crossref_primary_10_1111_j_1365_2796_2008_02045_x crossref_primary_10_1126_science_1152622 crossref_primary_10_1128_JVI_05201_11 crossref_primary_10_1038_nature05115 crossref_primary_10_1016_j_vaccine_2011_07_132 crossref_primary_10_1038_s41559_018_0509_3 crossref_primary_10_1371_journal_pcbi_0020071 crossref_primary_10_1371_journal_ppat_1000917 crossref_primary_10_4236_oji_2025_151001 crossref_primary_10_1097_QAD_0b013e32832d9267 crossref_primary_10_1128_JVI_01499_21 crossref_primary_10_1016_j_vaccine_2009_07_039 crossref_primary_10_1071_SH04057 crossref_primary_10_1038_s41467_022_33267_z crossref_primary_10_1128_JVI_00689_12 crossref_primary_10_3389_fimmu_2017_01591 crossref_primary_10_1097_01_aids_0000218560_67155_1c crossref_primary_10_1097_QAD_0b013e328330b489 crossref_primary_10_1016_j_molimm_2012_10_015 crossref_primary_10_1016_j_humimm_2013_08_287 crossref_primary_10_1038_srep42470 crossref_primary_10_1111_iji_12490 crossref_primary_10_1128_JVI_00821_08 crossref_primary_10_1128_JVI_02050_06 crossref_primary_10_1097_COH_0b013e3282f9ae8b crossref_primary_10_1371_journal_pgen_1002514 crossref_primary_10_1128_JVI_01596_09 crossref_primary_10_20538_1682_0363_2019_1_119_130 crossref_primary_10_4049_jimmunol_1700502 crossref_primary_10_1002_eji_200939451 crossref_primary_10_1097_BOR_0b013e328362018f crossref_primary_10_1097_QAD_0b013e32833e5009 crossref_primary_10_1371_journal_pcbi_1000225 crossref_primary_10_1084_jem_20041455 crossref_primary_10_1371_journal_pcbi_1002525 crossref_primary_10_1371_journal_ppat_1005247 crossref_primary_10_3390_v10120677 crossref_primary_10_1097_QAD_0b013e328353bcaf crossref_primary_10_1371_journal_pbio_1002144 crossref_primary_10_4049_jimmunol_175_4_2459 crossref_primary_10_1073_pnas_0811271106 crossref_primary_10_1016_j_humimm_2011_05_003 crossref_primary_10_1016_j_humgen_2024_201324 crossref_primary_10_1128_JVI_01958_08 crossref_primary_10_3390_math10010096 crossref_primary_10_1007_s00251_017_0974_x crossref_primary_10_1086_529528 crossref_primary_10_1016_j_vaccine_2014_05_021 crossref_primary_10_1002_hep_22242 crossref_primary_10_1038_ni1206_1281 crossref_primary_10_3109_00365548_2015_1007474 crossref_primary_10_1186_s12979_022_00310_y crossref_primary_10_1111_tan_13085 crossref_primary_10_1016_j_immuni_2014_12_011 crossref_primary_10_1097_QAD_0b013e32834981b3 crossref_primary_10_1038_s41431_022_01070_5 crossref_primary_10_1111_j_1365_3156_2005_01441_x crossref_primary_10_1084_jem_20072457 crossref_primary_10_1186_s12977_018_0390_9 crossref_primary_10_1084_jem_20071261 crossref_primary_10_1128_JVI_02329_09 crossref_primary_10_1128_spectrum_01613_23 crossref_primary_10_1517_14712590802571928 crossref_primary_10_1172_JCI98463 crossref_primary_10_1128_JVI_01004_14 crossref_primary_10_1097_COH_0b013e3282f5122a crossref_primary_10_1002_hep_23101 crossref_primary_10_1097_QAD_0b013e32832c492a crossref_primary_10_1128_JVI_01236_09 crossref_primary_10_1128_JVI_00968_06 crossref_primary_10_3389_fimmu_2019_00428 crossref_primary_10_1186_1476_9433_5_1 crossref_primary_10_1038_nature07352 crossref_primary_10_1371_journal_ppat_1003041 crossref_primary_10_1097_MD_0000000000003734 crossref_primary_10_1128_JVI_00306_09 crossref_primary_10_1371_journal_pone_0000591 crossref_primary_10_1073_pnas_0707570104 crossref_primary_10_3389_fimmu_2022_886562 crossref_primary_10_1038_news_2010_582 crossref_primary_10_1073_pnas_1413339111 crossref_primary_10_1038_ni_3147 crossref_primary_10_1111_j_1348_0421_2010_00206_x crossref_primary_10_1093_infdis_jiz589 crossref_primary_10_3389_fimmu_2018_02539 crossref_primary_10_1203_PDR_0b013e31818a07b1 crossref_primary_10_1038_nri2357 crossref_primary_10_1128_JVI_02025_19 crossref_primary_10_1016_j_immuni_2016_09_015 crossref_primary_10_1371_journal_pone_0067016 crossref_primary_10_1089_aid_2008_0208 crossref_primary_10_1371_journal_pcbi_1010355 crossref_primary_10_4049_jimmunol_181_4_2626 crossref_primary_10_1016_j_molimm_2015_07_007 crossref_primary_10_3389_fimmu_2018_01561 crossref_primary_10_1007_s00251_009_0399_2 crossref_primary_10_1371_journal_pone_0023469 crossref_primary_10_1089_aid_2006_0114 crossref_primary_10_1371_journal_pone_0000225 crossref_primary_10_1128_JVI_01120_09 crossref_primary_10_1371_journal_pcbi_0020024 crossref_primary_10_1128_JVI_02014_05 crossref_primary_10_1016_j_ebiom_2021_103258 crossref_primary_10_1186_s12967_014_0217_y crossref_primary_10_25259_IJDVL_654_19 crossref_primary_10_1038_ni1281 crossref_primary_10_1093_infdis_jiae448 crossref_primary_10_1186_s12977_015_0179_z crossref_primary_10_1128_JVI_02119_05 crossref_primary_10_1016_j_celrep_2014_03_031 crossref_primary_10_1016_j_vaccine_2008_03_100 crossref_primary_10_1051_mmnp_20127507 crossref_primary_10_1089_aid_2022_0082 crossref_primary_10_1186_1742_4690_10_139 crossref_primary_10_1186_s12977_022_00591_7 crossref_primary_10_1084_jem_20080569 crossref_primary_10_1128_JVI_00800_08 crossref_primary_10_1016_j_celrep_2019_12_087 crossref_primary_10_1186_s13059_017_1385_x crossref_primary_10_1128_JVI_07077_11 crossref_primary_10_1016_j_vaccine_2007_12_004 crossref_primary_10_4049_jimmunol_1100691 crossref_primary_10_1128_jvi_00811_22 crossref_primary_10_1371_journal_ppat_1002049 crossref_primary_10_1097_QAD_0b013e32810c8bbc crossref_primary_10_1007_s00251_015_0848_z crossref_primary_10_1371_journal_ppat_1001196 crossref_primary_10_1128_JVI_00719_19 crossref_primary_10_1155_2014_321974 crossref_primary_10_1111_jvh_13011 crossref_primary_10_1042_BST20220244 crossref_primary_10_1016_j_micinf_2011_03_009 crossref_primary_10_1128_JVI_02477_16 crossref_primary_10_1007_s10709_009_9354_2 crossref_primary_10_1186_1742_4690_5_68 crossref_primary_10_3389_fimmu_2018_01855 crossref_primary_10_1074_jbc_M113_468975 crossref_primary_10_1097_QAD_0000000000000969 crossref_primary_10_1128_JVI_02455_07 crossref_primary_10_1097_QAD_0000000000000728 crossref_primary_10_1128_JVI_00147_14 crossref_primary_10_1097_01_COH_0000232347_15909_22 crossref_primary_10_1128_JVI_07020_11 crossref_primary_10_1146_annurev_immunol_031210_101332 crossref_primary_10_1371_journal_ppat_1006638 crossref_primary_10_1093_ilar_ilt043 crossref_primary_10_1128_JVI_00171_10 crossref_primary_10_1128_JVI_00811_18 crossref_primary_10_1128_JVI_01084_10 crossref_primary_10_1007_s00251_010_0493_5 crossref_primary_10_1128_JVI_01128_17 crossref_primary_10_1016_j_ebiom_2018_09_022 crossref_primary_10_2119_molmed_2016_00031 crossref_primary_10_1371_journal_pone_0001424 crossref_primary_10_1371_journal_ppat_1005661 crossref_primary_10_2217_17469600_2_4_351 crossref_primary_10_1517_14712598_2014_885946 crossref_primary_10_1159_000369209 crossref_primary_10_1002_eji_201040841 crossref_primary_10_1016_j_heliyon_2025_e41836 crossref_primary_10_1128_JVI_79_17_11247_11258_2005 crossref_primary_10_1097_QAD_0b013e32834d3c4f crossref_primary_10_1126_science_1232685 crossref_primary_10_1093_infdis_jis198 crossref_primary_10_1097_QAI_0b013e3181fe946e crossref_primary_10_1182_bloodadvances_2022007005 crossref_primary_10_1128_JVI_01966_10 crossref_primary_10_1097_COH_0b013e3282fbaa92 crossref_primary_10_1186_1742_4690_6_72 crossref_primary_10_1097_QAD_0000000000002800 crossref_primary_10_1128_JVI_00022_07 crossref_primary_10_3389_fimmu_2020_00070 crossref_primary_10_4049_jimmunol_1400854 crossref_primary_10_1038_sj_gene_6364368 crossref_primary_10_1371_journal_pone_0034134 crossref_primary_10_1016_j_humimm_2012_04_021 crossref_primary_10_1128_JVI_01151_20 crossref_primary_10_1128_JVI_01381_12 crossref_primary_10_1089_vim_2005_18_500 crossref_primary_10_2217_17460794_1_1_55 crossref_primary_10_1007_s13312_018_1248_x crossref_primary_10_1097_01_aids_0000247589_77061_f7 crossref_primary_10_1128_JVI_01061_08 crossref_primary_10_1126_scitranslmed_aag1048 crossref_primary_10_1038_ni1241 crossref_primary_10_1097_QAD_0b013e3283021a8c crossref_primary_10_1371_journal_pcbi_1000981 crossref_primary_10_1371_journal_pone_0011436 crossref_primary_10_1097_01_COH_0000194102_28063_7c crossref_primary_10_1038_nri_2016_19 crossref_primary_10_1146_annurev_immunol_032712_100001 crossref_primary_10_1146_annurev_immunol_042617_053402 crossref_primary_10_4049_jimmunol_181_1_649 crossref_primary_10_4110_in_2023_23_e17 crossref_primary_10_4049_jimmunol_1202466 crossref_primary_10_1093_infdis_jiw555 crossref_primary_10_1126_science_1131528 crossref_primary_10_1111_j_1600_6143_2011_03863_x crossref_primary_10_1371_journal_ppat_0020077 crossref_primary_10_1186_s12977_016_0300_y crossref_primary_10_1371_journal_ppat_0020079 crossref_primary_10_1155_2012_508967 crossref_primary_10_3390_v6083271 crossref_primary_10_1093_hmg_dds226 crossref_primary_10_1186_s12977_015_0149_5 crossref_primary_10_1128_JVI_01162_14 crossref_primary_10_1371_journal_pone_0134037 crossref_primary_10_1038_nm1520 crossref_primary_10_1016_j_ijbiomac_2024_131356 crossref_primary_10_3389_fimmu_2019_01124 crossref_primary_10_3390_v4091711 crossref_primary_10_1097_COH_0b013e328361faf4 crossref_primary_10_1126_science_1195271 crossref_primary_10_1371_journal_pone_0022680 crossref_primary_10_1097_QAD_0000000000002704 crossref_primary_10_1097_01_aids_0000199827_79983_66 crossref_primary_10_1371_journal_ppat_1001033 crossref_primary_10_1128_JVI_01277_07 crossref_primary_10_1128_JVI_01955_15 crossref_primary_10_4049_jimmunol_181_7_5137 crossref_primary_10_1097_QAI_0b013e3181fe9450 crossref_primary_10_1097_QAD_0b013e32835e1616 crossref_primary_10_1128_jvi_00791_24 crossref_primary_10_1016_j_bbrc_2019_10_196 crossref_primary_10_4049_jimmunol_1101970 crossref_primary_10_1371_journal_ppat_1010090 crossref_primary_10_1016_j_meegid_2012_04_011 crossref_primary_10_3390_jcm11071855 crossref_primary_10_1186_1742_4690_4_62 crossref_primary_10_1371_journal_pone_0023515 crossref_primary_10_4049_jimmunol_176_8_4699 crossref_primary_10_1128_JVI_00320_10 crossref_primary_10_3390_vaccines6020018 crossref_primary_10_1128_JVI_06682_11 crossref_primary_10_1007_s00430_019_00585_x crossref_primary_10_1128_JVI_01998_12 crossref_primary_10_1007_s00705_015_2480_5 crossref_primary_10_1093_cid_cis188 crossref_primary_10_1093_cid_civ219 crossref_primary_10_1097_01_COH_0000221596_41788_52 crossref_primary_10_1007_s00251_011_0552_6 crossref_primary_10_3389_fimmu_2019_00177 crossref_primary_10_1007_s00251_009_0369_8 crossref_primary_10_1182_blood_2011_11_395384 crossref_primary_10_4049_jimmunol_2001405 crossref_primary_10_1016_j_immuni_2012_09_005 crossref_primary_10_1016_j_micinf_2010_10_006 crossref_primary_10_1016_j_virol_2014_08_009 crossref_primary_10_1111_tan_12051 crossref_primary_10_1371_journal_pone_0019018 crossref_primary_10_1086_526786 crossref_primary_10_1371_journal_pone_0001954 crossref_primary_10_1371_journal_pone_0018164 crossref_primary_10_1111_imm_12344 crossref_primary_10_1128_JVI_00569_12 crossref_primary_10_1053_j_gastro_2019_02_003 crossref_primary_10_1089_aid_2006_0080 crossref_primary_10_1128_JVI_00895_07 crossref_primary_10_1016_j_it_2018_07_004 crossref_primary_10_1073_pnas_1718659115 crossref_primary_10_1016_j_jid_2020_12_037 crossref_primary_10_1002_jmv_20848 crossref_primary_10_1097_QAI_0b013e318059beaa crossref_primary_10_1097_QAD_0000000000002976 crossref_primary_10_1007_s00251_017_1006_6 crossref_primary_10_1371_journal_ppat_1000033 crossref_primary_10_1371_journal_ppat_1003423 crossref_primary_10_3389_fimmu_2021_634832 crossref_primary_10_1016_j_meegid_2015_11_007 crossref_primary_10_1016_j_humimm_2021_01_008 crossref_primary_10_3389_fgene_2021_720213 crossref_primary_10_7554_eLife_34961 crossref_primary_10_1111_imr_12071 crossref_primary_10_7554_eLife_54558 crossref_primary_10_1128_JVI_02017_08 crossref_primary_10_1099_vir_0_022772_0 crossref_primary_10_1182_blood_2012_12_472787 crossref_primary_10_1128_JVI_02428_14 crossref_primary_10_1146_annurev_genom_7_080505_115726 crossref_primary_10_1038_s41409_023_02183_1 crossref_primary_10_1016_j_virol_2012_08_033 crossref_primary_10_1128_JVI_02543_10 crossref_primary_10_1186_1742_4690_9_39 crossref_primary_10_1128_JVI_00276_16 crossref_primary_10_1128_JVI_02520_10 crossref_primary_10_1093_infdis_jiq143 crossref_primary_10_1097_QAD_0000000000000206 crossref_primary_10_1086_520588 crossref_primary_10_1097_QAD_0000000000002868 crossref_primary_10_1097_QAD_0000000000000322 crossref_primary_10_1016_j_humimm_2019_12_003 crossref_primary_10_1371_journal_pcbi_0040015 crossref_primary_10_1128_JVI_00460_11 crossref_primary_10_1084_jem_20201908 crossref_primary_10_1186_s12865_016_0166_8 crossref_primary_10_4049_jimmunol_182_3_1526 crossref_primary_10_1016_j_imlet_2013_09_002 crossref_primary_10_1371_journal_pone_0286507 crossref_primary_10_3390_vaccines11051000 crossref_primary_10_1073_pnas_1204199109 crossref_primary_10_1371_journal_ppat_0030127 crossref_primary_10_1097_QAD_0000000000000574 crossref_primary_10_1128_JVI_01580_06 crossref_primary_10_4049_jimmunol_1004234 crossref_primary_10_4049_jimmunol_1302253 crossref_primary_10_1038_gene_2014_14 crossref_primary_10_4049_jimmunol_1004231 crossref_primary_10_1084_jem_20162123 crossref_primary_10_1186_1742_4690_7_92 crossref_primary_10_1371_journal_pone_0017043 crossref_primary_10_4049_jimmunol_177_7_4699 crossref_primary_10_1086_529387 crossref_primary_10_1128_JVI_01545_08 crossref_primary_10_1002_asia_201100306 crossref_primary_10_1016_j_vaccine_2008_01_012 crossref_primary_10_3748_wjg_v12_i30_4788 crossref_primary_10_4049_jimmunol_176_7_4094 crossref_primary_10_1038_nm1461 crossref_primary_10_1371_journal_ppat_0030045 crossref_primary_10_1111_j_1399_0039_2009_01337_x crossref_primary_10_1097_QAD_0b013e3282f42412 crossref_primary_10_3390_v14061270 crossref_primary_10_1007_s00251_007_0233_7 crossref_primary_10_2217_pgs_09_121 crossref_primary_10_1371_journal_ppat_1000242 crossref_primary_10_1371_journal_ppat_1000365 crossref_primary_10_1016_j_jim_2009_11_002 crossref_primary_10_1016_j_jhep_2013_08_009 crossref_primary_10_1128_JVI_00580_08 crossref_primary_10_1016_j_bjid_2019_04_009 crossref_primary_10_1128_JVI_03297_12 crossref_primary_10_1103_PhysRevE_108_044407 crossref_primary_10_4049_jimmunol_1101726 crossref_primary_10_1016_j_coi_2005_07_012 crossref_primary_10_1038_s41576_020_00305_9 crossref_primary_10_1016_j_vaccine_2017_08_070 crossref_primary_10_3389_fimmu_2017_00832 crossref_primary_10_1016_j_autrev_2008_03_013 crossref_primary_10_1016_j_virol_2010_05_026 crossref_primary_10_1128_JVI_02171_12 crossref_primary_10_1073_pnas_1009136107 crossref_primary_10_1128_JVI_01636_06 crossref_primary_10_1371_journal_pone_0026096 crossref_primary_10_1111_imcb_12698 crossref_primary_10_1128_JVI_00730_09 crossref_primary_10_1128_JVI_01882_08 crossref_primary_10_1098_rstb_2014_0290 crossref_primary_10_1097_QAD_0b013e3282f88d1b crossref_primary_10_1371_journal_ppat_1004954 crossref_primary_10_1590_1678_4685_gmb_2023_0198 crossref_primary_10_2217_17584310_3_1_79 crossref_primary_10_1097_QAD_0000000000001202 crossref_primary_10_1371_journal_pone_0010751 crossref_primary_10_1097_QAD_0b013e328182df03 crossref_primary_10_1016_S0140_6736_07_61051_4 crossref_primary_10_1097_QAI_0b013e31816fdc4a crossref_primary_10_1371_journal_pone_0136417 crossref_primary_10_1126_science_aav5095 crossref_primary_10_1128_JVI_01543_07 crossref_primary_10_1111_j_1399_0039_2005_00527_x crossref_primary_10_1016_j_jmgm_2017_07_033 crossref_primary_10_1002_hep_21702 crossref_primary_10_1089_aid_2010_0227 crossref_primary_10_1097_QAI_0b013e3181cf30ba crossref_primary_10_4049_jimmunol_2001145 crossref_primary_10_1016_j_bbrc_2022_03_108 crossref_primary_10_1093_infdis_jit581 crossref_primary_10_1016_j_immuni_2007_08_010 crossref_primary_10_1097_COH_0000000000000918 crossref_primary_10_1097_INF_0b013e3181e5a0fe crossref_primary_10_1016_j_omtm_2019_07_008 crossref_primary_10_1128_JVI_02032_14 crossref_primary_10_1097_QAD_0b013e328302f39f crossref_primary_10_1371_journal_ppat_1008177 crossref_primary_10_1080_2162402X_2021_1986943 crossref_primary_10_1053_j_gastro_2011_02_060 crossref_primary_10_1016_j_cub_2005_04_050 crossref_primary_10_1371_journal_pone_0269390 crossref_primary_10_1371_journal_pgen_1004196 crossref_primary_10_1097_COH_0000000000000807 crossref_primary_10_1128_JVI_02636_06 crossref_primary_10_1097_QAD_0000000000002559 crossref_primary_10_4049_jimmunol_181_9_6361 crossref_primary_10_1093_infdis_jis379 crossref_primary_10_1099_vir_0_82357_0 crossref_primary_10_1186_s12879_020_4786_5 crossref_primary_10_1016_j_humimm_2011_01_003 crossref_primary_10_1128_JVI_01962_09 crossref_primary_10_1155_2012_153863 crossref_primary_10_1371_journal_ppat_1008171 crossref_primary_10_1128_JVI_01472_10 crossref_primary_10_3389_fimmu_2018_03032 crossref_primary_10_1089_aid_2013_0067 crossref_primary_10_1128_JVI_80_7_3617_3623_2006 crossref_primary_10_4049_jimmunol_0903745 crossref_primary_10_4049_jimmunol_1601955 crossref_primary_10_1016_j_jviromet_2006_04_009 crossref_primary_10_1016_j_antiviral_2009_08_007 crossref_primary_10_1016_j_vaccine_2015_02_037 crossref_primary_10_1186_1479_5876_9_212 crossref_primary_10_1038_icb_2014_112 crossref_primary_10_1093_cid_cir811 crossref_primary_10_1089_vim_2009_0084 crossref_primary_10_1186_1742_4690_8_54 crossref_primary_10_1128_JVI_02742_06 crossref_primary_10_1097_QAD_0b013e32836146cd crossref_primary_10_1128_JVI_01847_06 crossref_primary_10_1371_journal_pbio_1001523 crossref_primary_10_4049_jimmunol_1002236 crossref_primary_10_1128_CVI_00169_07 crossref_primary_10_1128_JVI_02031_09 crossref_primary_10_3390_microorganisms12010155 crossref_primary_10_1186_1479_5876_9_208 crossref_primary_10_1371_journal_pone_0005013 crossref_primary_10_1089_aid_2013_0197 crossref_primary_10_1098_rspb_2013_0696 crossref_primary_10_1016_j_yamp_2020_07_016 crossref_primary_10_1016_j_compbiolchem_2019_107195 crossref_primary_10_1084_jem_20081984 crossref_primary_10_1128_JVI_80_10_5074_5077_2006 crossref_primary_10_1016_j_str_2024_04_015 crossref_primary_10_5339_gcsp_2014_60 crossref_primary_10_1128_JVI_06728_11 crossref_primary_10_1186_1742_4690_10_53 crossref_primary_10_1097_QAD_0000000000002213 crossref_primary_10_1126_science_1110009 crossref_primary_10_3389_fimmu_2022_769900 crossref_primary_10_1371_journal_pone_0073117 crossref_primary_10_1128_JVI_00544_17 crossref_primary_10_1016_j_molimm_2006_06_003 crossref_primary_10_1128_JVI_00286_10 |
Cites_doi | 10.1038/357326a0 10.1038/nri1417 10.1016/S1286-4579(00)01287-9 10.1034/j.1399-0039.2002.600301.x 10.1002/eji.1830070816 10.1126/science.272.5258.67 10.1056/NEJM200105313442203 10.1073/pnas.91.13.5893 10.1038/nm992 10.1126/science.1069660 10.1038/nm893 10.1097/00042560-200204150-00009 10.1128/JVI.77.3.2081-2092.2003 10.1038/ng934 10.1056/NEJM199908053410602 10.1038/35103577 10.1128/JVI.77.22.12083-12087.2003 10.1126/science.272.5265.1167 10.1038/35073658 10.1126/science.283.5408.1748 10.1038/nm0496-405 10.1073/pnas.071548198 10.1073/pnas.050567397 10.1016/S1471-4914(01)02131-1 10.1038/357329a0 10.1097/00002030-200405210-00009 |
ContentType | Journal Article |
Copyright | Macmillan Magazines Ltd. 2005 2005 INIST-CNRS COPYRIGHT 2004 Nature Publishing Group Copyright Macmillan Journals Ltd. Dec 9, 2004 |
Copyright_xml | – notice: Macmillan Magazines Ltd. 2005 – notice: 2005 INIST-CNRS – notice: COPYRIGHT 2004 Nature Publishing Group – notice: Copyright Macmillan Journals Ltd. Dec 9, 2004 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM ATWCN 3V. 7QG 7QL 7QP 7QR 7RV 7SN 7SS 7ST 7T5 7TG 7TK 7TM 7TO 7U9 7X2 7X7 7XB 88A 88E 88G 88I 8AF 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK 8G5 ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BEC BENPR BGLVJ BHPHI BKSAR C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M2M M2O M2P M7N M7P M7S MBDVC NAPCQ P5Z P62 P64 PATMY PCBAR PDBOC PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ PTHSS PYCSY Q9U R05 RC3 S0X SOI 7X8 7SC 7SP 7SR 7TB 7U5 8BQ F28 JG9 JQ2 KR7 L7M L~C L~D |
DOI | 10.1038/nature03113 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Middle School ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Meteorological & Geoastrophysical Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection eLibrary ProQuest Central Technology Collection Natural Science Collection Earth, Atmospheric & Aquatic Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection ProQuest Biological Science Collection Agricultural Science Database ProQuest Health & Medical Collection Medical Database Psychology Database Research Library Science Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Research Library (Corporate) Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Earth, Atmospheric & Aquatic Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology Engineering Collection Environmental Science Collection ProQuest Central Basic University of Michigan Genetics Abstracts SIRS Editorial Environment Abstracts MEDLINE - Academic Computer and Information Systems Abstracts Electronics & Communications Abstracts Engineered Materials Abstracts Mechanical & Transportation Engineering Abstracts Solid State and Superconductivity Abstracts METADEX ANTE: Abstracts in New Technology & Engineering Materials Research Database ProQuest Computer Science Collection Civil Engineering Abstracts Advanced Technologies Database with Aerospace Computer and Information Systems Abstracts Academic Computer and Information Systems Abstracts Professional |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database ProQuest One Psychology Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts elibrary ProQuest AP Science SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Earth, Atmospheric & Aquatic Science Database Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) University of Michigan Technology Collection Technology Research Database ProQuest One Academic Middle East (New) SIRS Editorial Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central Earth, Atmospheric & Aquatic Science Collection ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Research Library ProQuest Materials Science Collection ProQuest Public Health ProQuest Central Basic ProQuest Science Journals ProQuest Nursing & Allied Health Source ProQuest Psychology Journals (Alumni) ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library ProQuest Psychology Journals Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic Materials Research Database Civil Engineering Abstracts Computer and Information Systems Abstracts – Academic Mechanical & Transportation Engineering Abstracts Electronics & Communications Abstracts ProQuest Computer Science Collection Computer and Information Systems Abstracts METADEX Computer and Information Systems Abstracts Professional Engineered Materials Abstracts Solid State and Superconductivity Abstracts Advanced Technologies Database with Aerospace ANTE: Abstracts in New Technology & Engineering |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE Agricultural Science Database Materials Research Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) Physics |
EISSN | 1476-4687 |
EndPage | 775 |
ExternalDocumentID | 771766891 A186286327 15592417 16328802 10_1038_nature03113 |
Genre | Journal Article |
GeographicLocations | Africa, Southern |
GeographicLocations_xml | – name: Africa, Southern |
GroupedDBID | --- --Z -DZ -ET -~X .-4 .55 .GJ .HR 00M 08P 0R~ 0WA 123 186 1VR 29M 2KS 2XV 39C 3EH 3O- 3V. 4.4 41X 42X 53G 5RE 6TJ 70F 7RV 7X2 7X7 7XC 85S 88A 88E 88I 8AF 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ 8G5 8R4 8R5 8WZ 97F 97L 9M8 A6W A7Z A8Z AAEEF AAHBH AAHTB AAIKC AAJYS AAKAB AAMNW AASDW AAYEP AAYOK AAYZH ABAWZ ABDBF ABDPE ABDQB ABEFU ABFSI ABIVO ABJCF ABJNI ABLJU ABNNU ABOCM ABPEJ ABPPZ ABTAH ABUWG ABWJO ABZEH ACBEA ACBWK ACGFO ACGFS ACGOD ACIWK ACKOT ACMJI ACNCT ACPRK ACRPL ACTDY ACUHS ACWUS ADBBV ADFRT ADNMO ADUKH ADYSU AENEX AEUYN AFFDN AFFNX AFHKK AFKRA AFLOW AFRAH AFSHS AGAYW AGCDD AGGDT AGHSJ AGHTU AGNAY AGSOS AHMBA AHSBF AIDAL AIDUJ AIYXT ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH APEBS ARAPS ARTTT ASPBG ATCPS ATWCN AVWKF AXYYD AZFZN AZQEC B0M BBNVY BCU BDKGC BEC BENPR BGLVJ BHPHI BIN BKEYQ BKKNO BKOMP BKSAR BPHCQ BVXVI CCPQU CJ0 CS3 D1I D1J D1K DB5 DO4 DU5 DWQXO E.- E.L EAD EAP EAS EAZ EBC EBD EBO EBS ECC EE. EJD EMB EMF EMH EMK EMOBN EPL EPS ESE ESN ESX EX3 EXGXG F5P FEDTE FQGFK FSGXE FYUFA GNUQQ GUQSH HCIFZ HG6 HMCUK HVGLF HZ~ I-F IAO ICQ IEA IEP IGS IH2 IHR INH INR IOF IPY ISR ITC J5H K6- KB. KOO L-9 L6V L7B LK5 LK8 M0K M0L M1P M2M M2O M2P M7P M7R M7S MVM N4W N9A NAPCQ NEJ NEPJS O9- OBC OES OHH OHT OMK OVD P-O P2P P62 PATMY PCBAR PDBOC PKN PM3 PQQKQ PROAC PSQYO PSYQQ PTHSS PYCSY Q2X R05 RND RNS RNT RNTTT RXW S0X SC5 SJFOW SJN SNYQT SOJ SV3 TAE TAOOD TEORI TH9 TN5 TSG TUS TWZ U5U UIG UKHRP UKR UMD UQL USG VOH VQA VVN WH7 WOW X7L X7M XIH XKW XZL Y6R YAE YCJ YFH YIF YIN YNT YOC YQJ YQT YR2 YR5 YV5 YXB YYP YZZ Z5M ZCA ZCG ZGI ZHY ZKB ZKG ZY4 ~02 ~7V ~88 ~8M ~KM .CO .XZ 07C 1CY 1OL 1VW 354 41~ 4R4 663 79B AAKAS AARCD AAVBQ AAYXX ABFSG ACBNA ACBTR ACMFV ACSTC ADGHP ADRHT ADXHL ADZCM AETEA AEZWR AFANA AFBBN AFHIU AGQPQ AHWEU AIXLP AJUXI ALPWD ARMCB ATHPR BCR BES BLC CITATION FA8 FAC LGEZI LOTEE LSO NADUK NFIDA NXXTH ODYON PEA PHGZM PHGZT PV9 QS- R4F RHI SHXYY SIXXV SKT TBHMF TDRGL TUD UBY UHB XOL YJ6 YQI YXA YYQ ZE2 ~G0 IQODW PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM AEIIB PMFND 7QG 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7TG 7TK 7TM 7TO 7U9 7XB 8FD 8FK C1K FR3 H94 K9. KL. M7N MBDVC P64 PKEHL PQEST PQUKI PRINS Q9U RC3 SOI 7X8 7SC 7SP 7SR 7TB 7U5 8BQ F28 JG9 JQ2 KR7 L7M L~C L~D |
ID | FETCH-LOGICAL-c684t-964e84a9dca4e289fbdda25d093b26ef04834c3507647ca0faff1fbd283f96033 |
IEDL.DBID | 7X7 |
ISSN | 0028-0836 1476-4687 |
IngestDate | Fri Jul 11 03:06:08 EDT 2025 Fri Jul 11 06:41:59 EDT 2025 Fri Jul 11 06:35:48 EDT 2025 Sat Aug 23 13:16:21 EDT 2025 Fri Jun 13 00:45:40 EDT 2025 Tue Jun 10 15:35:29 EDT 2025 Tue Jun 10 21:28:29 EDT 2025 Fri Jun 27 05:39:44 EDT 2025 Fri Jun 27 05:41:58 EDT 2025 Wed Feb 19 01:39:31 EST 2025 Mon Jul 21 09:15:07 EDT 2025 Thu Apr 24 23:04:16 EDT 2025 Tue Jul 01 04:10:30 EDT 2025 Fri Feb 21 02:37:54 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7018 |
Keywords | Immune response HIV-1 virus Retroviridae Host agent relation Lentivirus Virus Molecular evolution HLA-A-Locus Histocompatibility restriction Human immunodeficiency virus Class I histocompatibility antigen HLA-B-Locus Polymorphism |
Language | English |
License | http://www.springer.com/tdm CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c684t-964e84a9dca4e289fbdda25d093b26ef04834c3507647ca0faff1fbd283f96033 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
PMID | 15592417 |
PQID | 204555591 |
PQPubID | 40569 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_743167943 proquest_miscellaneous_67184536 proquest_miscellaneous_17699214 proquest_journals_204555591 gale_infotracgeneralonefile_A186286327 gale_infotraccpiq_186286327 gale_infotracacademiconefile_A186286327 gale_incontextgauss_ISR_A186286327 gale_incontextgauss_ATWCN_A186286327 pubmed_primary_15592417 pascalfrancis_primary_16328802 crossref_primary_10_1038_nature03113 crossref_citationtrail_10_1038_nature03113 springer_journals_10_1038_nature03113 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2004-12-09 |
PublicationDateYYYYMMDD | 2004-12-09 |
PublicationDate_xml | – month: 12 year: 2004 text: 2004-12-09 day: 09 |
PublicationDecade | 2000 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationSubtitle | International weekly journal of science |
PublicationTitle | Nature (London) |
PublicationTitleAbbrev | Nature |
PublicationTitleAlternate | Nature |
PublicationYear | 2004 |
Publisher | Nature Publishing Group UK Nature Publishing Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing – name: Nature Publishing Group |
References | PM Garcia (BFnature03113_CR16) 1999; 341 AJ McMichael (BFnature03113_CR5) 2001; 410 D Snary (BFnature03113_CR9) 1977; 7 JW Mellors (BFnature03113_CR11) 1996; 272 AJ Leslie (BFnature03113_CR28) 2004; 10 MM Addo (BFnature03113_CR10) 2003; 77 SA Migueles (BFnature03113_CR19) 2000; 97 PO Flores-Villanueva (BFnature03113_CR22) 2001; 98 SGE Marsh (BFnature03113_CR3) 2000 M Badri (BFnature03113_CR12) 2004; 18 M Bunce (BFnature03113_CR27) 2003; 210 CB Moore (BFnature03113_CR14) 2002; 296 DI Watkins (BFnature03113_CR7) 1992; 357 SJ O'Brien (BFnature03113_CR18) 2001; 7 SN McAdam (BFnature03113_CR8) 1994; 91 MP Belich (BFnature03113_CR6) 1992; 357 RA Kaslow (BFnature03113_CR17) 1996; 2 P Parham (BFnature03113_CR2) 1996; 272 E Trachtenberg (BFnature03113_CR21) 2003; 9 ER Cooper (BFnature03113_CR15) 2002; 29 GS Cooke (BFnature03113_CR24) 2001; 2 X Gao (BFnature03113_CR20) 2001; 344 M Carrington (BFnature03113_CR4) 1999; 283 PJ Goulder (BFnature03113_CR13) 2004; 4 CL Thio (BFnature03113_CR26) 2003; 77 KJ Jeffery (BFnature03113_CR1) 2000; 2 M Ramos (BFnature03113_CR25) 2002; 60 MP Martin (BFnature03113_CR23) 2002; 31 |
References_xml | – volume: 357 start-page: 326 year: 1992 ident: BFnature03113_CR6 publication-title: Nature doi: 10.1038/357326a0 – volume: 4 start-page: 630 year: 2004 ident: BFnature03113_CR13 publication-title: Nature Rev. Immunol. doi: 10.1038/nri1417 – volume: 2 start-page: 1335 year: 2000 ident: BFnature03113_CR1 publication-title: Microbes Infect. doi: 10.1016/S1286-4579(00)01287-9 – volume: 60 start-page: 191 year: 2002 ident: BFnature03113_CR25 publication-title: Tissue Antigens doi: 10.1034/j.1399-0039.2002.600301.x – volume: 7 start-page: 580 year: 1977 ident: BFnature03113_CR9 publication-title: Eur. J. Immunol. doi: 10.1002/eji.1830070816 – volume: 272 start-page: 67 year: 1996 ident: BFnature03113_CR2 publication-title: Science doi: 10.1126/science.272.5258.67 – volume: 344 start-page: 1668 year: 2001 ident: BFnature03113_CR20 publication-title: N. Engl. J. Med. doi: 10.1056/NEJM200105313442203 – volume: 91 start-page: 5893 year: 1994 ident: BFnature03113_CR8 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.91.13.5893 – volume: 10 start-page: 282 year: 2004 ident: BFnature03113_CR28 publication-title: Nature Med. doi: 10.1038/nm992 – volume: 296 start-page: 1439 year: 2002 ident: BFnature03113_CR14 publication-title: Science doi: 10.1126/science.1069660 – volume: 9 start-page: 928 year: 2003 ident: BFnature03113_CR21 publication-title: Nature Med. doi: 10.1038/nm893 – volume: 29 start-page: 484 year: 2002 ident: BFnature03113_CR15 publication-title: J. Acquir. Immune Defic. Syndr. doi: 10.1097/00042560-200204150-00009 – volume: 77 start-page: 2081 year: 2003 ident: BFnature03113_CR10 publication-title: J. Virol. doi: 10.1128/JVI.77.3.2081-2092.2003 – volume: 31 start-page: 429 year: 2002 ident: BFnature03113_CR23 publication-title: Nature Genet. doi: 10.1038/ng934 – volume: 341 start-page: 394 year: 1999 ident: BFnature03113_CR16 publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199908053410602 – volume: 2 start-page: 967 year: 2001 ident: BFnature03113_CR24 publication-title: Nature Rev. Genet. doi: 10.1038/35103577 – volume: 77 start-page: 12083 year: 2003 ident: BFnature03113_CR26 publication-title: J. Virol. doi: 10.1128/JVI.77.22.12083-12087.2003 – volume: 272 start-page: 1167 year: 1996 ident: BFnature03113_CR11 publication-title: Science doi: 10.1126/science.272.5265.1167 – volume: 410 start-page: 980 year: 2001 ident: BFnature03113_CR5 publication-title: Nature doi: 10.1038/35073658 – volume: 283 start-page: 1748 year: 1999 ident: BFnature03113_CR4 publication-title: Science doi: 10.1126/science.283.5408.1748 – volume: 210 start-page: 143 year: 2003 ident: BFnature03113_CR27 publication-title: Methods Mol. Biol. – volume-title: The HLA Facts Book year: 2000 ident: BFnature03113_CR3 – volume: 2 start-page: 405 year: 1996 ident: BFnature03113_CR17 publication-title: Nature Med. doi: 10.1038/nm0496-405 – volume: 98 start-page: 5140 year: 2001 ident: BFnature03113_CR22 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.071548198 – volume: 97 start-page: 2709 year: 2000 ident: BFnature03113_CR19 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.050567397 – volume: 7 start-page: 379 year: 2001 ident: BFnature03113_CR18 publication-title: Trends Mol. Med. doi: 10.1016/S1471-4914(01)02131-1 – volume: 357 start-page: 329 year: 1992 ident: BFnature03113_CR7 publication-title: Nature doi: 10.1038/357329a0 – volume: 18 start-page: 1159 year: 2004 ident: BFnature03113_CR12 publication-title: AIDS doi: 10.1097/00002030-200405210-00009 |
SSID | ssj0005174 |
Score | 2.3998737 |
Snippet | The extreme polymorphism in the human leukocyte antigen (HLA) class I region of the human genome is suggested to provide an advantage in pathogen defence... |
SourceID | proquest gale pubmed pascalfrancis crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 769 |
SubjectTerms | Africa, Southern Antigens Biological and medical sciences Biological Evolution CD8-Positive T-Lymphocytes - cytology CD8-Positive T-Lymphocytes - immunology Epitopes, T-Lymphocyte - immunology Evolution Female Fundamental and applied biological sciences. Psychology Gene Frequency Gene Products, nef - chemistry Genomics HIV Infections - immunology HIV Infections - virology HIV-1 - genetics HIV-1 - immunology HIV-1 - physiology HLA-A Antigens - genetics HLA-A Antigens - immunology HLA-B Antigens - genetics HLA-B Antigens - immunology Human immunodeficiency virus 1 Humanities and Social Sciences Humans Infant letter Leukocytes Male Microbiology multidisciplinary nef Gene Products, Human Immunodeficiency Virus Pathogens Peptides Polymorphism, Genetic - genetics Replicative cycle, interference, host-virus relations, pathogenicity, miscellaneous strains Science Science (multidisciplinary) Viral Load Virology |
Title | Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA |
URI | https://link.springer.com/article/10.1038/nature03113 https://www.ncbi.nlm.nih.gov/pubmed/15592417 https://www.proquest.com/docview/204555591 https://www.proquest.com/docview/17699214 https://www.proquest.com/docview/67184536 https://www.proquest.com/docview/743167943 |
Volume | 432 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgExISQmx8hUGx0PiUrCWx48RPqCsrHYIKlQ36FjmOPU1CSUZa_n7OidMu0NKHPNS_1B93OV_qu98hdJhoISKtIqLyjBLGWUKk8hlRxmdxrkUgpM1G_jLlk3P2aR7NXWxO7cIqO5vYGOq8VPY_8iNLmw4fEbyvrogtGmUPV10FjZto1zKX2YiueB6vIzz-ImF26Xk-TY5a1kxQ6ID2NiRnlu9UsoYlMm1ti03O5z8Hp81-NL6H7jpHEg9bye-hG7rYR7eagE5V76M999DW-I1jln57H80-lG3kC77sapPg0uDJ5yE5hq9wk0Zi46AxuIW4Khc2lAg6USXRv52ONjecfseyyO2ND9D5-ORsNCGuqAJRPGELIjjTCZMiV5JpeNsyWZ7LMMp9QbOQa2Mp5pmi4CZyFivpG2lMACBwQwy87VD6EO0UZaEfIyy40WAu8jyOJWMSPB9tFIe9MGM6Vizz0LtuZVPlGMdt4YufaXPyTZP0mhg8dLgCVy3RxhaYFVFqqSsKGxtzIZd1nQ7Pfoym6TBIbKYtDWMPvdgEO_0264FeO5ApYVxKuowEmJ0lxeohD3pIVV1epddaX_VaL1qxbvqZQU-x1hOFVjCkIfTTaVrqbEmdrjTfQ89XrWAE7MmOLHS5rNMg5kKEAduO4OCDsIhyD-EtiLghRRAMlvhRq-Pr4UHv4OnB-F92Sr8e3gYhPfnvNA7Q7Y4t0xdP0c7i11I_A89ukQ2a5xeuySiw1_HHAdo9Ppl-nf0B4MhOaA |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemIQQSQmx8hcFmoY0vKVo-HCd-QKhsTC3r-jA66JtxHHuahJKMtCD-KP5HzonTLtDytj7Gl_rjznfn-O53CO0mirFIyciVWRq6hJLEFdIjrtQeiTPFfCZMNvLJiPbPyMdJNFlDv9tcGBNW2erEWlFnhTTfyPcNbDr8mP-uvHRN0ShzudpW0Gik4lj9-gknturt4BDYuxcERx_GB33XFhVwJU3I1GWUqIQIlklBFJw2dJplIogyONmnAVXaQKwTGYKbREkshaeF1j4QgRnW4O2b75-g8W-A3fXMhoon8SKi5C_QZ5sO6IXJfoPSCRvIDzsG0JqBO6WogCW6qaWxzNn956K2tn9H99Bd67jiXiNpG2hN5ZvoZh1AKqtNtGGVRIVfWSTr1_fR6WHRRNrgi7YWCi407g977nt4hOu0FRN3jcENxWUxNaFL0IksXPXD7on6hcFnLPLMvPgAnV3Lej9E63mRq8cIM6oVqKcsi2NBiABPS2lJwfamRMWSpA56064slxbh3BTa-Mbrm_Yw4VfY4KDdOXHZAHusIDMs4gYqIzexOOdiVlW8N_5yMOI9PzGZvWEQO-j5MrLBp9MO0UtLpAsYlxQ2AwJmZ0C4OpRbHUpZXlzyK60vOq3nDVuX_c12R7AWE4VWUNwB9NNKGre6q-LzneagnXkrKB1zkyRyVcwq7seUscAnqyko-DwkCqmD8AqKuAZhYASW-FEj44vhQe_gWcL491qhXwxvCZOe_HcaO-hWf3wy5MPB6HgL3W6ROj32FK1Pv8_UM_Aqp-l2vZcx-nrdyuMP4xGImA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemIRASQmzAKIPNQhtfUtQmcez4AaGyUrVsVGhs0DfPcexpEko60oL40_jvOCdOu0DL2_oYX-qP-_A5vvsdQnux5jzSKvJUmoQeoST2pOoQT5kOYanmPpc2G_njiA5OyYdxNF5Dv-tcGBtWWdvE0lCnubLfyNsWNh1-3G8bFxXxqdd_O7n0bAEpe9FaV9OoJORQ__oJp7fizbAHrN4Pgv77k4OB5woMeIrGZOpxSnRMJE-VJBpOHiZJUxlEKZzyk4BqY-HWiQrBZaKEKdkx0hgfiGBLNuD522-hYP1vsDDyrYqxMVtEl_wFAO1SAzth3K4QO0GZ_LCxGbot4c5EFsAeU9XVWOb4_nNpW-6F_XvornNicbeSug20prNNdLMMJlXFJtpwBqPALx2q9av76LiXV1E3-KKui4JzgwdHXe8dPMJlCouNwcbgkuJJPrVhTNCJyj39w-lH-cLwC5ZZal98gE6vZb0fovUsz_QjhDk1GkxVmjImCZHgdWmjKOzDCdFMkaSFXtcrK5RDO7dFN76J8tY9jMUVNrTQ3px4UoF8rCCzLBIWNiOzEnguZ0UhuidfD0ai68c2yzcMWAs9W0Y2_HzcIHrhiEwO41LSZUPA7CwgV4Nyu0GpJheX4krr80brecXWZX-z0xCsxUShFYx4AP3UkiacHSvEXOtaaHfeCgbI3irJTOezQviMch74ZDUFBf-HRCFtIbyCgpWADJzAEm9VMr4YHvQOXiaMf78W-sXwljDp8X-nsYtugdkQR8PR4Ta6XYN2dvgTtD79PtNPwcGcJjulKmN0dt224w9ruozO |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dominant+influence+of+HLA-B+in+mediating+the+potential+co-evolution+of+HIV+and+hla&rft.jtitle=Nature+%28London%29&rft.au=KIEPIELA%2C+Photini&rft.au=LESLIE%2C+Alasdair+J&rft.au=ZIMBWA%2C+Peter&rft.au=MOORE%2C+Sarah&rft.date=2004-12-09&rft.pub=Nature+Publishing&rft.issn=0028-0836&rft.volume=432&rft.issue=7018&rft.spage=769&rft.epage=774&rft_id=info:doi/10.1038%2Fnature03113&rft.externalDBID=n%2Fa&rft.externalDocID=16328802 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-0836&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-0836&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-0836&client=summon |